Showing results (1-10 of 192) with videos related to
Sort By:
Pageof 20
Current Opinion in Supportive and Palliative Care|July 3, 2013
The changing landscape in metastatic castration-resistant prostate cancerRaya Leibowitz-Amit, Anthony M JoshuaCancer Cell|November 13, 2019
Companion Diagnostics to Identify Biomarkers of Response to Anticancer Drugs Targeting the ProteomeAnthony M Joshua, Ian F TannockMethods in Molecular Medicine|May 6, 2008
Web-based resources for clinical bioinformaticsAnthony M Joshua, Paul C BoutrosCancer Research|November 14, 2020
Fats and Mets, KRAS-Driven Lipid Dysregulation Affects Metastatic Potential in Pancreatic CancerJennifer Man, Marina Pajic, Anthony M JoshuaCancers|April 20, 2017
AR Signaling and the PI3K Pathway in Prostate CancerMegan Crumbaker, Leila Khoja, Anthony M JoshuaAsia-Pacific Journal of Clinical Oncology|April 24, 2019
Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary centerMegan Crumbaker, Jean Wong, Anthony M Joshua, et al.BJU International|October 7, 2016
Understanding the role of new systemic agents in the treatment of prostate cancerJulia Corfield, Jack Crozier, Anthony M Joshua, et al.Cancers|September 28, 2021
PARP Inhibitors in Melanoma-An Expanding Therapeutic Option?Wei Yen Chan, Lauren J Brown, Lee Reid, et al.ANZ Journal of Surgery|June 14, 2006
Advances in the adjuvant treatment of colorectal cancerIna C Nordman, Shoba Iyer, Anthony M Joshua, et al.Anti-Cancer Drugs|December 3, 2009
Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenibCaroline Chung, Laura A Dawson, Anthony M Joshua, et al.Pageof 20